Guopei Zheng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Transforming Growth Factor

Positive Breast Cancer

Top Venues

Clinical and translational medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Liyun Luo, Ning Xu, Weina Fan, Yixuan Wu, Pingping Chen, Zhihui Li, Zhimin He, Hao Liu, Ying Lin, Guopei Zheng
The TGFβ2-Snail1-miRNA TGFβ2 Circuitry is Critical for the Development of Aggressive Functions in Breast Cancer. Clinical and translational medicine 14 (2) (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)
Liyun Luo, Ning Xu, Weina Fan, Yixuan Wu, Pingping Chen, Zhihui Li, Zhimin He, Hao Liu, Ying Lin, Guopei Zheng
The TGFβ2-Snail1-miRNA TGFβ2 Circuitry is Critical for the Development of Aggressive Functions in Breast Cancer. Clinical and translational medicine 14 (2) (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)
Liyun Luo, Ning Xu, Weina Fan, Yixuan Wu, Pingping Chen, Zhihui Li, Zhimin He, Hao Liu, Ying Lin, Guopei Zheng
The TGFβ2-Snail1-miRNA TGFβ2 Circuitry is Critical for the Development of Aggressive Functions in Breast Cancer. Clinical and translational medicine 14 (2) (2024)
Xiaoting Jia, Ge Wang, Lihong Wu, Hao Pan, Li Ling, Jianlei Zhang, Qingquan Wen, Jie Cui, Zhimin He, Bin Qi, Shuxu Zhang, Liyun Luo, Guopei Zheng
XBP1-elicited environment by chemotherapy potentiates repopulation of tongue cancer cells by enhancing miR-22/lncRNA/KAT6B-dependent NF-κB signalling. Clinical and translational medicine 13 (1) (2023)
Xiaoting Jia, Ge Wang, Lihong Wu, Hao Pan, Li Ling, Jianlei Zhang, Qingquan Wen, Jie Cui, Zhimin He, Bin Qi, Shuxu Zhang, Liyun Luo, Guopei Zheng
XBP1-elicited environment by chemotherapy potentiates repopulation of tongue cancer cells by enhancing miR-22/lncRNA/KAT6B-dependent NF-κB signalling. Clinical and translational medicine 13 (1) (2023)
Xiaoting Jia, Ge Wang, Lihong Wu, Hao Pan, Li Ling, Jianlei Zhang, Qingquan Wen, Jie Cui, Zhimin He, Bin Qi, Shuxu Zhang, Liyun Luo, Guopei Zheng
XBP1-elicited environment by chemotherapy potentiates repopulation of tongue cancer cells by enhancing miR-22/lncRNA/KAT6B-dependent NF-κB signalling. Clinical and translational medicine 13 (1) (2023)
Xiaoting Jia, Ge Wang, Lihong Wu, Hao Pan, Li Ling, Jianlei Zhang, Qingquan Wen, Jie Cui, Zhimin He, Bin Qi, Shuxu Zhang, Liyun Luo, Guopei Zheng
XBP1-elicited environment by chemotherapy potentiates repopulation of tongue cancer cells by enhancing miR-22/lncRNA/KAT6B-dependent NF-κB signalling. Clinical and translational medicine 13 (1) (2023)
Hao Liu, Xiaoting Jia, Kai Luo, Xiangzhou Chen, Zhijie Zhang, Danyang Chen, Yixue Gu, Zhi-Min He, Guopei Zheng
TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a. Oncogenesis 11 (1) (2022)
Hao Liu, Hui Lyu, Guanmin Jiang, Danyang Chen, Sanbao Ruan, Shuang Liu, Lukun Zhou, Minqiang Yang, Shanshan Zeng, Zhi-Min He, Hong-Sheng Wang, Hong-Sheng Li, Guopei Zheng, Xiaolong Liu
ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer. Cancer research 82 (21) (2022)
Liyun Luo, Zhijie Zhang, Ni Qiu, Li Ling, Xiaoting Jia, Ying Song, Hongsheng Li, Jiansheng Li, Hui Lyu, Hao Liu, Zhi-Min He, Xiaolong Liu, Guopei Zheng
Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer. Nature communications 12 (1) (2021)